REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 533.87B
Enterprise Value 330.9B
Trailing P/E 14.70
Forward P/E 112.98
PEG Ratio (5 yr expected) 11.69
Price/Sales (ttm)4.90
Price/Book (mrq)3.60
Enterprise Value/Revenue 34.47
Enterprise Value/EBITDA 611.84

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 35.12%
Operating Margin (ttm)35.41%

Management Effectiveness

Return on Assets (ttm)13.76%
Return on Equity (ttm)30.32%

Income Statement

Revenue (ttm)6.91B
Revenue Per Share (ttm)63.86
Quarterly Revenue Growth (yoy)13.30%
Gross Profit (ttm)4.09B
EBITDA 2.61B
Net Income Avi to Common (ttm)2.43B
Diluted EPS (ttm)21.11
Quarterly Earnings Growth (yoy)-3.50%

Balance Sheet

Total Cash (mrq)3.23B
Total Cash Per Share (mrq)29.5
Total Debt (mrq)709.9M
Total Debt/Equity (mrq)7.52
Current Ratio (mrq)4.58
Book Value Per Share (mrq)86.22

Cash Flow Statement

Operating Cash Flow (ttm)2.47B
Levered Free Cash Flow (ttm)1.22B

Trading Information

Stock Price History

Beta (3Y Monthly) 0.96
52-Week Change 32.01%
S&P500 52-Week Change 33.92%
52 Week High 3442.00
52 Week Low 3291.10
50-Day Moving Average 3352.14
200-Day Moving Average 3381.30

Share Statistics

Avg Vol (3 month) 3812.53k
Avg Vol (10 day) 3886.73k
Shares Outstanding 5107.25M
Float 81.51M
% Held by Insiders 124.61%
% Held by Institutions 172.68%
Shares Short (Apr 30, 2019) 42.65M
Short Ratio (Apr 30, 2019) 43.04
Short % of Float (Apr 30, 2019) 43.32%
Short % of Shares Outstanding (Apr 30, 2019) 42.42%
Shares Short (prior month Mar 29, 2019) 42.09M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A